Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Sudarshan Sukhani of s2analytics.com is of the view that one may make money in GAIL India by next week as the stock is breaking out.
Sudarshan Sukhani of s2analytics.com recommends buying GAIL India at current levels as the stock may head higher.
Manas Jaiswal of manasjaiswal.com recommends going long in GAIL India as the stock may test Rs 375 in next two to three trading sessions.
Sudarshan Sukhani of s2analytics.com is of the view that one may see higher levels in GAIL India.
Sudarshan Sukhani of s2analytics.com is of the view that GAIL India may test Rs 355-357 on the upside.
According to Sudarshan Sukhani of s2analytics.com, one may buy GAIL India.
Rajeev Agarwal of dynamixresearch.in suggests selling GAIL India with a target of Rs 333-323 and Housing Development and Infrastructure (HDIL) with a target of Rs 46-42.
According to Sudarshan Sukhani of s2analytics.com, one may see higher levels in GAIL India.
According to Pritesh Mehta, senior technical analyst at IIFL, GAIL India may test Rs 350 in the neat term.
Aditya Agarwal of Way2Wealth recommends buying GAIL India with a target of Rs 348 and a stoploss at Rs 327.
Vikrant Jadeja of Vibrant Trades suggests buying Gail India with a target of Rs 345 and Cadila Healthcare with a target of Rs 780.
Sudarshan Sukhani of s2analytics.com recommends going long in GAIL India for short term as well as for a medium term.
GAIL will have zero-subsidy burden for the rest of the year, but there is no official communication about FY15, so ICICI Securities is estimating Rs 1400 crore as subsidy for GAIL for next year, Rohit Ahuja explains.
VK Sharma of HDFC Securities recommends buying GAIL India Rs 360 Call at around Rs 3 with a target of Rs 7.
Sudarshan Sukhani of s2analytics.com recommends buying GAIL.
Meghna Malkan of malkansview.com suggets selling Bank of India with a stoploss at Rs 180 and ACC with a stoploss at Rs 1145.
Abhijit Paul of Alphative Advisors recommends holding GAIL for a period of six months to one year as the stock may test Rs 400.
Shardul Kulkarni of Angel Broking is of the view that above Rs 325-328, GAIL may touch Rs 355-360.
SP Tulsian of sptulsian.com has a neutral stance on GAIL because it has been facing problems in its pipeline.
Sudarshan Sukhani of s2analytics.com recommends selling GAIL India as it is bearish and is heading back to Rs 275.
Sudarshan Sukhani of s2analytics.com is of the opinion that one may buy GAIL India on strength.
Sudarshan Sukhani of s2analytics.com is of the opinion that one may buy Glenmark Pharma as the stock has been rallying and is in a bull market of its own.
Bank Nifty will continue to fall for some time now. Sudarshan Sukhani suggests shorting IndusInd Bank next week. He is positive on the pharma sector and has a ‘Buy‘ on Glenmark Pharma and GAIL.
Dilip Bhat is pretty upbeat about Infosys and says nobody should look at the stock from a single (current) quarter point of view, considering that the change of management has just happened
Manas Jaiswal of manasjaiswal.com recommends buying a Global Beverage at current levels with a stop loss of Rs 138 and advices to buy United Spirits at current levels with a stop loss of Rs 2,450.